EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Novel Role of Copper Transporter CTR1 and Therapeutic Potential of Copper Chelators in Retinal Ischemia-Reperfusion Injury

Mai Yamamoto, Dipankar Ash, Varadarajan Sudhahar, Syed Adeel H Zaidi, Modesto A Rojas, Zhimin Xu, Stephanie Kelley Spears, Ruth B Caldwell, Tohru Fukai, Masuko Ushio-Fukai

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.12.70 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Mai Yamamoto and 9 co-authors. Institution: Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia, United States. Major MEDLINE topics: Reperfusion Injury, Cation Transport Proteins, Copper, Chelating Agents. Cited 7 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NHLBI NIH HHS, NEI NIH HHS, BLRD VA.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Retinal ischemia contributes to vision loss in ischemic and diabetic retinopathies through oxidative stress, neurovascular injury, and inflammation. Copper (Cu), whereas an essential micronutrient, can be toxic in excess and is regulated by Cu transporters such as CTR1. However, the role of CTR1 in ischemic retinopathy remains unclear. Methods and Results: Retinal ischemia-reperfusion (IR) injury was induced by elevating intraocular pressure (IOP) to 110 millimeters of mercury (mm Hg) for 40 minutes in the right eyes of Ctr1 heterozygous (Ctr1+/-) and wild-type (WT) mice. In WT mice, IR triggered rapid CTR1 upregulation and increased retinal Cu levels (measured by inductively coupled plasma mass spectrometry [ICP-MS]). IR injury caused retinal ganglion cell (RGC) loss, inner retinal thinning, vascular degeneration, and apoptosis, all of which were significantly attenuated in Ctr1+/- mice. Ctr1+/- mice also exhibited reduced microglial (Iba1⁺) and glial cells (GFAP⁺) activation and preserved visual function, as assessed by electroretinography. Mechanistically, IR-induced reactive oxygen species (\({{\rm{O}}_{2}}^{-}\)) production (DHE staining), upregulation of NADPH oxidase components (NOX2 and p47phox), and NF-κB activation were markedly suppressed in Ctr1+/- mice. Treatment with the Cu chelator tetrathiomolybdate (TTM) similarly reduced retinal thinning, neurovascular damage, apoptosis, gliosis, and oxidative stress after IR injury.

Conclusions

CTR1 plays a central role in mediating Cu-dependent oxidative stress, neurovascular degeneration, and inflammation following retinal IR injury. Targeting the CTR1-Cu axis may represent a novel therapeutic strategy for ischemic retinopathy.

Subjects

MeSH terms (MEDLINE)

Reperfusion InjuryCation Transport ProteinsCopperChelating AgentsRetinal DiseasesAnimalsMiceCopper Transporter 1Mice, Inbred C57BLRetinal Ganglion CellsDisease Models, AnimalElectroretinographyOxidative StressApoptosisBlotting, WesternMaleMolybdenum

Substances

Cation Transport ProteinsCopper Transporter 1CopperSlc31a1 protein, mouseChelating AgentstetrathiomolybdateMolybdenum

Authors and institutions

  • Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
  • Culver Vision Discovery Institute, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
  • Department of Medicine (Cardiology), Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
  • Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, United States.
  • Department of Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
  • Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.

Funding

  • NHLBI NIH HHS
  • NEI NIH HHS
  • BLRD VA
  • American Heart Association-American Stroke Association
  • NIH HHS

Cite

APA

Yamamoto, M., Ash, D., Sudhahar, V., Zaidi, S. A. H., Rojas, M. A., Xu, Z., Kelley Spears, S., Caldwell, R. B., Fukai, T., & Ushio-Fukai, M. (2025). Novel Role of Copper Transporter CTR1 and Therapeutic Potential of Copper Chelators in Retinal Ischemia-Reperfusion Injury. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.12.70

Vancouver

Yamamoto M, Ash D, Sudhahar V, Zaidi SAH, Rojas MA, Xu Z, et al. Novel Role of Copper Transporter CTR1 and Therapeutic Potential of Copper Chelators in Retinal Ischemia-Reperfusion Injury. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.12.70

BibTeX
@article{Yamamoto2025,
  author = {Yamamoto, Mai and Ash, Dipankar and Sudhahar, Varadarajan and Zaidi, Syed Adeel H and Rojas, Modesto A and Xu, Zhimin and Kelley Spears, Stephanie and Caldwell, Ruth B and Fukai, Tohru and Ushio-Fukai, Masuko},
  title = {Novel Role of Copper Transporter CTR1 and Therapeutic Potential of Copper Chelators in Retinal Ischemia-Reperfusion Injury},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.12.70}
}
Start for free →